These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 3456247)
1. The sensitivity to cytosine arabinoside of the blast progenitors of acute myeloblastic leukemia. Nara N; Curtis JE; Senn JS; Tritchler DL; McCulloch EA Blood; 1986 Mar; 67(3):762-9. PubMed ID: 3456247 [TBL] [Abstract][Full Text] [Related]
2. Relationship between the in vitro sensitivity to cytosine arabinoside of blast progenitors and the outcome of treatment in acute myeloblastic leukaemia patients. Nara N; Suzuki T; Nagata K; Yamashita Y; Murohashi I; Adachi Y Br J Haematol; 1988 Oct; 70(2):187-91. PubMed ID: 3191030 [TBL] [Abstract][Full Text] [Related]
3. A comparison of the lethal effects in culture of cytosine arabinoside and arabinofuranosyl-5-azacytosine acting on the blast cells fo acute myeloblastic leukemia. Yang GS; McCulloch EA Hematol Pathol; 1992; 6(3):125-30. PubMed ID: 1385380 [TBL] [Abstract][Full Text] [Related]
4. Sensitivity to 5-azacytidine of blast progenitors in acute myeloblastic leukemia. Wang C; McCulloch EA Blood; 1987 Feb; 69(2):553-9. PubMed ID: 2432971 [TBL] [Abstract][Full Text] [Related]
5. Hydrocortisone in culture protects the blast cells in acute myeloblastic leukemia from the lethal effects of cytosine arabinoside. Yang GS; Wang C; Minkin S; Minden MD; McCulloch EA J Cell Physiol; 1991 Jul; 148(1):60-7. PubMed ID: 1860896 [TBL] [Abstract][Full Text] [Related]
6. Regulation by retinoic acid and hydrocortisone of the anthracycline sensitivity of blast cells of acute myeloblastic leukemia. Yang GS; Minden MD; McCulloch EA Leukemia; 1994 Dec; 8(12):2065-75. PubMed ID: 7807996 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the proliferative activity and sensitivity to cytosine arabinoside of leukemic blast progenitors in acute myeloblastic leukemia at diagnosis and in relapse. Nara N; Tohda S; Suzuki T; Nagata K; Tanikawa S; Imai Y; Tomiyama J; Shiina S Acta Haematol; 1992; 88(1):17-21. PubMed ID: 1414157 [TBL] [Abstract][Full Text] [Related]
8. A cell culture model for the treatment of acute myeloblastic leukemia with fludarabine and cytosine arabinoside. Rayappa C; McCulloch EA Leukemia; 1993 Jul; 7(7):992-9. PubMed ID: 8321050 [TBL] [Abstract][Full Text] [Related]
9. Comparative effects of busulfan, cytosine arabinoside and adriamycin on different maturation stages of normal human bone marrow cells. Tohda S; Nagata K; Suzuki T; Nara N Acta Haematol; 1990; 83(1):16-21. PubMed ID: 2105564 [TBL] [Abstract][Full Text] [Related]
10. Response to 5-azacytidine of leukemic blast cells in suspension: a biological parameter associated with response to chemotherapy. Wang C; Curtis JE; Senn JS; Tritchler DL; McCulloch EA Leukemia; 1987 Nov; 1(11):753-6. PubMed ID: 2446086 [TBL] [Abstract][Full Text] [Related]
11. Effects of rGM-CSF and rG-CSF on the cisplatin sensitivity of the blast cells of acute myeloblastic leukemia. Wang YF; Kelleher CA; Minkin S; McCulloch EA Leukemia; 1991 Mar; 5(3):239-48. PubMed ID: 1707468 [TBL] [Abstract][Full Text] [Related]
12. Influence of schedule on regulated sensitivity of AML blasts to cytosine arabinoside. Yang GS; Minden MD; McCulloch EA Leukemia; 1993 Jul; 7(7):1012-9. PubMed ID: 7686602 [TBL] [Abstract][Full Text] [Related]
13. Effects of purified human native granulocyte colony-stimulating factor (G-CSF) on proliferation of blast progenitors in acute myeloblastic leukemia. Nara N; Murohashi I; Suzuki T; Yamashita Y; Maruyama Y; Aoki N; Tanikawa S; Onozawa Y Am J Hematol; 1988 Feb; 27(2):84-8. PubMed ID: 3257647 [TBL] [Abstract][Full Text] [Related]
14. Granulocyte-macrophage colony-stimulating factor and interleukin-3 protect leukemic blast cells from ara-C toxicity. Koistinen P; Wang C; Curtis JE; McCulloch EA Leukemia; 1991 Sep; 5(9):789-95. PubMed ID: 1719308 [TBL] [Abstract][Full Text] [Related]
15. In vitro response of blasts to IL-3, GM-CSF, and G-CSF is different for individual AML patients: factors that stimulate leukemic clonogenic cells also enhance Ara-C cytotoxicity. Van der Lely N; De Witte T; Wessels J; Raymakers R; Muus P; Preijers F Ann Hematol; 1994 May; 68(5):225-32. PubMed ID: 7517190 [TBL] [Abstract][Full Text] [Related]
16. Fluorescence-labeling of nicks in DNA from leukemic blast cells as a measure of damage following cytosine arabinoside. Application to the study of regulated drug sensitivity. Yang GS; Wang C; Minden MD; McCulloch EA Leukemia; 1994 Dec; 8(12):2052-9. PubMed ID: 7807994 [TBL] [Abstract][Full Text] [Related]
17. Effect of stem cell factor on leukemic progenitor cell growth and sensitivity to cytosine-arabinoside. Viallard JF; Grosset C; Lacombe F; David S; Mahon FX; Barbot C; Vianes I; Dupouy M; Reiffers J Leuk Res; 1996; 20(11-12):915-23. PubMed ID: 9009249 [TBL] [Abstract][Full Text] [Related]
19. OCI/AML-4 an acute myeloblastic leukemia cell line: regulation and response to cytosine arabinoside. Koistinen P; Wang C; Yang GS; Wang YF; Williams DE; Lyman SD; Minden MD; McCulloch EA Leukemia; 1991 Aug; 5(8):704-11. PubMed ID: 1715961 [TBL] [Abstract][Full Text] [Related]
20. The proliferation in suspension of the progenitors of the blast cells in acute myeloblastic leukemia. Nara N; McCulloch EA Blood; 1985 Jun; 65(6):1484-93. PubMed ID: 3857945 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]